fluorodeoxyglucose f18 has been researched along with epiglucan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amazzough, K; Arvieux, C; Barete, S; Bougnoux, ME; Crabol, Y; Lanternier, F; Lecuit, M; Lortholary, O; Maunoury, C; Pineau, S; Poiree, S; Zeller, V | 1 |
| Eluvathingal, T; Fogel, B; Kothari, A; Mohan, M; Schinke, C | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and epiglucan
| Article | Year |
|---|---|
Last generation triazoles for imported eumycetoma in eleven consecutive adults.
Topics: Adolescent; Adult; Antifungal Agents; beta-Glucans; Child; Exophiala; Fluorodeoxyglucose F18; Fusarium; Humans; Madurella; Magnetic Resonance Imaging; Male; Mycetoma; Positron-Emission Tomography; Proteoglycans; Retrospective Studies; Skin; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Gastrointestinal histoplasmosis in a patient after autologous stem cell transplant for multiple myeloma.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; beta-Glucans; Colonoscopy; Fever; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Histoplasma; Histoplasmosis; Humans; Ileum; Intestinal Obstruction; Itraconazole; Lymphadenopathy; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Weight Loss | 2016 |